+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Generic Drugs Market Analysis 2019

  • ID: 4857794
  • Report
  • October 2019
  • Region: Global
  • 121 pages
  • Syngene Research

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Baxter International Inc.
  • Dr. Reddy’s
  • Fresenius Kabi Ag
  • Mylan NV
  • Novartis International AG
  • MORE
The Generic Drugs market is expected to reach $738.56 billion by 2026 growing at a CAGR of 12.6% from 2018 to 2026. Generic drugs are drugs with the chemical makeup of a drug equivalent to an existing branded drug. These drugs are cheaper and equivalent to branded drugs in dosage, strength, route of administration, quality, performance, and application. Generic drugs are subjected to government regulations in various countries rather than being associated with a particular company.

Factors such as the increasing prevalence of chronic diseases, diabetes & cardiovascular diseases, growing healthcare expenditure, high demand for generic medicines, and a large number of patent expired branded drugs are driving the market growth. Though, high competition and the shortage of drugs are hampering the market growth.

Based on the therapy area, anti-infective drugs are agents that act against infections either by inhibiting the spread of an infectious agent or by destroying the infectious agent. Anti-infective drugs are required to destroy infectious agents that cause several infections in the human body such as tuberculosis, sepsis, and smallpox.

The key vendors mentioned are Cipla, Abbott Laboratories, Novartis International AG, Nichi-Iko Pharmaceutical, Mylan NV, Valeant, Hospira (Pfizer Inc.), Dr. Reddy’s, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., STADA Arzneimittel AG, Fresenius Kabi Ag, Baxter International Inc., Actavis Pharmaceuticals, and Eli Lilly and Company.

Drug Deliveries Covered:
  • Dermal/Topical
  • Inhalers
  • Injectables
  • Oral
  • Parenteral
  • Other Drug Deliveries
Brands Covered:
  • Pure Generic Drugs
  • Branded Generic Drugs
Therapy Areas Covered:
  • Dermatology
  • Diabetes
  • Respiratory Products
  • Rheumatology
  • Oncology
  • Genitourinary/Hormonal
  • Gastrointestinal Disorders
  • Pain Management
Distribution Channels Covered:
  • Retail Pharmacies
  • Drug Stores
  • Hospitals
  • Private Clinics
  • Online Pharmacies
Therapeutic Drugs Covered:
  • Cardiovascular Products
  • Anti-Infective Drugs
  • Anti-Arthritis Drugs
  • Central Nervous System Drugs
  • Anti-Cancer Drug
  • Antibiotics
Categories Covered:
  • Bio-Similar
  • Small Molecule Generics
  • Super Generics
  • Simple Generics
Regions Covered:
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa
Key Questions Answered in this Report:
  • How this market evolved since the year 2016
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analysed during the forecast period

*Please Note: This report will be delivered within 48 hours of ordering.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Baxter International Inc.
  • Dr. Reddy’s
  • Fresenius Kabi Ag
  • Mylan NV
  • Novartis International AG
  • MORE
1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Generic Drugs Market, By Drug Delivery
5.1 Introduction
5.2 Dermal/Topical
5.3 Inhalers
5.4 Injectables
5.5 Oral
5.6 Parenteral
5.7 Other Drug Deliveries

6 Global Generic Drugs Market, By Brand
6.1 Introduction
6.2 Pure Generic Drugs
6.3 Branded Generic Drugs

7 Global Generic Drugs Market, By Therapy Area
7.1 Introduction
7.2 Dermatology
7.3 Diabetes
7.4 Respiratory Products
7.5 Rheumatology
7.6 Oncology
7.7 Genitourinary/Hormonal
7.8 Gastrointestinal Disorders
7.9 Pain Management

8 Global Generic Drugs Market, By Distribution Channel
8.1 Introduction
8.2 Retail Pharmacies
8.3 Drug Stores
8.4 Hospitals
8.5 Private Clinics
8.6 Online Pharmacies

9 Global Generic Drugs Market, By Therapeutic Drugs
9.1 Introduction
9.2 Cardiovascular Products
9.3 Anti-Infective Drugs
9.4 Anti-Arthritis Drugs
9.5 Central Nervous System Drugs
9.6 Anti-Cancer Drug
9.7 Antibiotics

10 Global Generic Drugs Market, By Category
10.1 Introduction
10.2 Bio-Similar
10.3 Small Molecule Generics
10.4 Super Generics
10.5 Simple Generics

11 Global Generic Drugs Market, By Geography
11.1 Introduction
11.2 North America
11.3 Europe
11.4 Asia Pacific
11.5 South America
11.6 Middle East & Africa

12 Strategic Benchmarking

13 Vendors Landscape
13.1 Cipla
13.2 Abbott Laboratories
13.3 Novartis International AG
13.4 Nichi-Iko Pharmaceutical
13.5 Mylan NV
13.6 Valeant
13.7 Hospira (Pfizer Inc.)
13.8 Dr. Reddy’s
13.9 Sun Pharmaceutical Industries Ltd.
13.10 Teva Pharmaceutical Industries Ltd.
13.11 STADA Arzneimittel AG
13.12 Fresenius Kabi Ag
13.13 Baxter International Inc.
13.14 Actavis Pharmaceuticals
13.15 Eli Lilly and Company

List of Data Tables
Table 1 Global Generic Drugs Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Generic Drugs Market Outlook, By Drug Delivery Region (2016-2026) ($MN)
Table 3 Global Generic Drugs Market Outlook, By Dermal/Topical Region (2016-2026) ($MN)
Table 4 Global Generic Drugs Market Outlook, By Inhalers Region (2016-2026) ($MN)
Table 5 Global Generic Drugs Market Outlook, By Injectables Region (2016-2026) ($MN)
Table 6 Global Generic Drugs Market Outlook, By Oral Region (2016-2026) ($MN)
Table 7 Global Generic Drugs Market Outlook, By Parenteral Region (2016-2026) ($MN)
Table 8 Global Generic Drugs Market Outlook, By Other Drug Deliveries Region (2016-2026) ($MN)
Table 9 Global Generic Drugs Market Outlook, By Brand Region (2016-2026) ($MN)
Table 10 Global Generic Drugs Market Outlook, By Pure Generic Drugs Region (2016-2026) ($MN)
Table 11 Global Generic Drugs Market Outlook, By Branded Generic Drugs Region (2016-2026) ($MN)
Table 12 Global Generic Drugs Market Outlook, By Therapy Area Region (2016-2026) ($MN)
Table 13 Global Generic Drugs Market Outlook, By Dermatology Region (2016-2026) ($MN)
Table 14 Global Generic Drugs Market Outlook, By Diabetes Region (2016-2026) ($MN)
Table 15 Global Generic Drugs Market Outlook, By Respiratory Products Region (2016-2026) ($MN)
Table 16 Global Generic Drugs Market Outlook, By Rheumatology Region (2016-2026) ($MN)
Table 17 Global Generic Drugs Market Outlook, By Oncology Region (2016-2026) ($MN)
Table 18 Global Generic Drugs Market Outlook, By Genitourinary/Hormonal Region (2016-2026) ($MN)
Table 19 Global Generic Drugs Market Outlook, By Gastrointestinal Disorders Region (2016-2026) ($MN)
Table 20 Global Generic Drugs Market Outlook, By Pain Management Region (2016-2026) ($MN)
Table 21 Global Generic Drugs Market Outlook, By Distribution Channel Region (2016-2026) ($MN)
Table 22 Global Generic Drugs Market Outlook, By Retail Pharmacies Region (2016-2026) ($MN)
Table 23 Global Generic Drugs Market Outlook, By Drug Stores Region (2016-2026) ($MN)
Table 24 Global Generic Drugs Market Outlook, By Hospitals Region (2016-2026) ($MN)
Table 25 Global Generic Drugs Market Outlook, By Private Clinics Region (2016-2026) ($MN)
Table 26 Global Generic Drugs Market Outlook, By Online Pharmacies Region (2016-2026) ($MN)
Table 27 Global Generic Drugs Market Outlook, By Therapeutic Drugs Region (2016-2026) ($MN)
Table 28 Global Generic Drugs Market Outlook, By Cardiovascular Products Region (2016-2026) ($MN)
Table 29 Global Generic Drugs Market Outlook, By Anti-Infective Drugs Region (2016-2026) ($MN)
Table 30 Global Generic Drugs Market Outlook, By Anti-Arthritis Drugs Region (2016-2026) ($MN)
Table 31 Global Generic Drugs Market Outlook, By Central Nervous System Drugs Region (2016-2026) ($MN)
Table 32 Global Generic Drugs Market Outlook, By Anti-Cancer Drug Region (2016-2026) ($MN)
Table 33 Global Generic Drugs Market Outlook, By Antibiotics Region (2016-2026) ($MN)
Table 34 Global Generic Drugs Market Outlook, By Category Region (2016-2026) ($MN)
Table 35 Global Generic Drugs Market Outlook, By Bio-Similar Region (2016-2026) ($MN)
Table 36 Global Generic Drugs Market Outlook, By Small Molecule Generics Region (2016-2026) ($MN)
Table 37 Global Generic Drugs Market Outlook, By Super Generics Region (2016-2026) ($MN)
Table 38 Global Generic Drugs Market Outlook, By Simple Generics Region (2016-2026) ($MN)
Table 39 North America Generic Drugs Market Outlook, By Drug Delivery (2016-2026) ($MN)
Table 40 North America Generic Drugs Market Outlook, By Brand (2016-2026) ($MN)
Table 41 North America Generic Drugs Market Outlook, By Therapy Area (2016-2026) ($MN)
Table 42 North America Generic Drugs Market Outlook, By Distribution Channel (2016-2026) ($MN)
Table 43 North America Generic Drugs Market Outlook, By Therapeutic Drugs (2016-2026) ($MN)
Table 44 North America Generic Drugs Market Outlook, By Category (2016-2026) ($MN)
Table 45 Europe Generic Drugs Market Outlook, By Drug Delivery (2016-2026) ($MN)
Table 46 Europe Generic Drugs Market Outlook, By Brand (2016-2026) ($MN)
Table 47 Europe Generic Drugs Market Outlook, By Therapy Area (2016-2026) ($MN)
Table 48 Europe Generic Drugs Market Outlook, By Distribution Channel (2016-2026) ($MN)
Table 49 Europe Generic Drugs Market Outlook, By Therapeutic Drugs (2016-2026) ($MN)
Table 50 Europe Generic Drugs Market Outlook, By Category (2016-2026) ($MN)
Table 51 Asia Pacific Generic Drugs Market Outlook, By Drug Delivery (2016-2026) ($MN)
Table 52 Asia Pacific Generic Drugs Market Outlook, By Brand (2016-2026) ($MN)
Table 53 Asia Pacific Generic Drugs Market Outlook, By Therapy Area (2016-2026) ($MN)
Table 54 Asia Pacific Generic Drugs Market Outlook, By Distribution Channel (2016-2026) ($MN)
Table 55 Asia Pacific Generic Drugs Market Outlook, By Therapeutic Drugs (2016-2026) ($MN)
Table 56 Asia Pacific Generic Drugs Market Outlook, By Category (2016-2026) ($MN)
Table 57 South America Generic Drugs Market Outlook, By Drug Delivery (2016-2026) ($MN)
Table 58 South America Generic Drugs Market Outlook, By Brand (2016-2026) ($MN)
Table 59 South America Generic Drugs Market Outlook, By Therapy Area (2016-2026) ($MN)
Table 60 South America Generic Drugs Market Outlook, By Distribution Channel (2016-2026) ($MN)
Table 61 South America Generic Drugs Market Outlook, By Therapeutic Drugs (2016-2026) ($MN)
Table 62 South America Generic Drugs Market Outlook, By Category (2016-2026) ($MN)
Table 63 Middle East & Africa Generic Drugs Market Outlook, By Drug Delivery (2016-2026) ($MN)
Table 64 Middle East & Africa Generic Drugs Market Outlook, By Brand (2016-2026) ($MN)
Table 65 Middle East & Africa Generic Drugs Market Outlook, By Therapy Area (2016-2026) ($MN)
Table 66 Middle East & Africa Generic Drugs Market Outlook, By Distribution Channel (2016-2026) ($MN)
Table 67 Middle East & Africa Generic Drugs Market Outlook, By Therapeutic Drugs (2016-2026) ($MN)
Table 68 Middle East & Africa Generic Drugs Market Outlook, By Category (2016-2026) ($MN)
Note: Product cover images may vary from those shown
  • Cipla
  • Abbott Laboratories
  • Novartis International AG
  • Nichi-Iko Pharmaceutical
  • Mylan NV
  • Valeant
  • Hospira (Pfizer Inc.)
  • Dr. Reddy’s
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • STADA Arzneimittel AG
  • Fresenius Kabi Ag
  • Baxter International Inc.
  • Actavis Pharmaceuticals
  • Eli Lilly and Company
Note: Product cover images may vary from those shown
Adroll
adroll